Skip to main content

Virtual visit appointments available 7 days a week from 9:00am to 11:00pm. Learn More

COVID-19 Updates

COVID-19 Updates: Get the latest on vaccine information, in-person appointments, virtual visits and more. Learn More

Notice: Street Closure

Street Closure: Texas Medical Center Campus road closures, September 29 - October 1, that will impact patients and visitors. Learn More | En Español

Murali Chintagumpala, MD


Texas Medical Center

Cancer and Hematology
Phone: 832-822-4266
Fax: 832-825-1456


6621 Fannin St., Ste. 1510.15
Houston, TX 77030

Murali M. Chintagumpala, MD

Clinical Director, Brain Tumor Program
Co-Director, Retinoblastoma Program
Professor, Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine


School Education Degree Year
Baylor College of Medicine Fellowship Hematology/Oncology 1992
Columbus Hospital Program Residency Pediatrics 1988
University Teaching Hospital Residency Jr. Resident Medical Officer 1984
Government General Hospital Internship Rotating Internship 1983
Madras Medical College Medical School Doctor of Medicine 1981


Dr. Murali Chintagumpala is Clinical Director of the Brain Tumor Program and Co-Director of the Retinoblastoma Program. He oversees all clinical and clinical research activities involving children with brain tumors and solid tumors at Texas Children's Cancer and Hematology Center. His specific interests include the management of children with all brain tumors, retinoblastoma, bone tumors, and kidney tumors. 

His extensive background in treating children with brain tumors has led him to become the Principal Investigator representing Baylor College of Medicine in the Pediatric Brain Tumor Consortium. He serves as member of the Brain Tumor Committee within the Children’s Oncology Group (COG) and serves an active role at Texas Children's Cancer Center where he is Co-Director of our Brain Tumor Program.

In addition, Dr. Chintagumpala is a Clinical Co-Director of the Retinoblastoma Center of Houston. At the national level, he serves as chair of the Retinoblastoma Committee within the Children’s Oncology Group and is a leader in conducting clinical trials involving children with retinoblastoma.

As Director of our Solid Tumor Programs, he is an experienced clinician expert in the management of children with bone tumors, liver tumors and kidney tumors. He is the principal investigator of a multi-institutional study designed to improve survival in patients with osteosarcoma as part of the Bone Tumor Program.

Dr. Chintagumpala is a graduate of Madras Medical College in India. He then completed his residency at Columbus Hospital in Chicago, Illinois, then attended Baylor College of Medicine where he graduated from the Fellowship Program in Pediatric Hematology/Oncology. He is board certified in pediatric Hematology/Oncology by the American Board of Pediatrics.

News Articles:

'Officer Abigail' suffers setback, but she's all smiles


Organization Name Role
American Society of Clinical Oncology (ASCO) Member
American Society of Pediatric Hematology and Oncology (ASPHO) Member
Children's Oncology Group (COG) Member
Children's Oncology Group (COG), Brain Tumor Committee Member
Children's Oncology Group (COG), Renal Tumors Committee Member
Children's Oncology Group (COG), Retinoblastoma Committee Chair
Pediatric Brain Tumor Consortium (PBTC) Member

Board Certification

American Board of Pediatrics - Pediatrics, American Board of Pediatrics - Pediatric Hematology-Oncology



Latest Videos

Q&A: Brain Tumor Program | Texas Children's Cancer Center

* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.